The gene expression index c-myc X E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 1, 1998, Pages 18-24

  DeMuth, Jeffrey P ^a   Jackson, Clara M ^a   Weaver, David A ^a   Crawford, Erin L ^a   Durzinsky, Dennis S ^a   Durham, Samuel J ^a   Zaher, Aiman ^a   Phillips, Edwin R ^a   Khuder, Sadik A ^a   Willey, James C ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; RETINOBLASTOMA BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1;

AGED; ARTICLE; BRONCHUS; CELL CULTURE; CELL CYCLE; CELL TRANSFORMATION; COMPARATIVE STUDY; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LUNG CARCINOMA; LUNG TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; ONCOGENE MYC; PATHOLOGY; POLYMERASE CHAIN REACTION;

AGED; BRONCHI; CARCINOMA, BRONCHOGENIC; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENES, MYC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032111673     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.1.3077     Document Type: Article

References (20)

1. Apostolakos, M. J., W. H. T. Schuermann, M. W. Frampton, M. J. Utell, and J. C. Willey. 1994. Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal. Biochem. 213:277-284.
2. Willey, J. C., E. L. Coy, C. Brolly, M. J. Utell, M. W. Frampton, J. Hammersley, W. G. Thilly, D. E. Olson, and K. Cairns. 1996. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am. J. Respir. Cell Mol. Biol. 14:262-271.
3. Willey, J. C., F. L. Coy, M. W. Frampton, A. Torres, M. J. Apostolakos, G. Hoehn, W. H. Schuermann, W. G. Thilly, D. E. Olson, J. R. Hammersley, C. L. Crespi, and M. J. Utell. 1947. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Cell Mol. Biol. 17:114-124.
4. Willey, J. C., E. L. Crawford, C. M. Jackson, D. A. Weaver, J. C. Hoban, S. A. Khuder, and J. P. DeMuth. 1998. Expression measurement of many genes simultaneously hy quantitative RT-PCR using standardized mixtures of competitive templates. Am. J. Respir. Cell Mol. Biol. 19:6-17.
5. Hunter, T. 1997. Oncoprotein networks. Cell 88:333-346.
6. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
7. Weinherg, R. A. 1996. E2F and cell proliferation: a world turned upside down. Cell 85:457-459.
8. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
9. Johnson, D. G., W. D. Cress, L. Jakoi, and J. R. Nevins. 1994. Oncogenic capacity of the E2F-1 gene. Proc. Natl. Acad. Sci. USA 91:12823-12827.
10. Hunter, T., and J. Pines. 1994. Cyclins and cancer: II. Cyclin D and CDK inhibitors conic of age. Cell 74:57.1-582.
11. Martin, S. J., and D. R. Green. 1995. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit. Rev. Oncol. Hematol. 18:137-153.
12. Rifkind, R. A., V. M. Richon, and P. A. Marks. 1996. Induced differentiation. the cell cycle, and the treatment of cancer. Pharmacol. Ther. 69:97-102.
13. Sancar, A. 1995. DNA repair in humans. Annu. Rev. Genet. 29:69-105.
14. Gartel, A. L., M. S. Serfas, and A. L. Tyner. 1996. p21, negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:138-149.
15. Harris, C. C. 1996. The 1995 Waller Hubert Lecture: molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumor-suppressor gene. Br. J. Cancer 73:261-269.
16. Harris, C. C., and M. Hollstein. 1993. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1318-1327.
17. Greenblatt, M. S., and C. C. Harris. 1995. Molecular genetics of lung cancer. Cancer Surv. 25:293-313.
18. Gazdar, A. F. 1994. The molecular and cellular basis of human lung cancel. Anticancer Res. 13:261-267.
19. Okamoto, A., S. P. Hussain, K. Hagiwara, E. A. Spillare, M. R. Rusin, D. J. Demetrick, M. Serrano, G. J. Hannon, M. Shiseki, M. Zariwala, Y. Xiong, D. H. Beach, J. Yokota, and C. C. Harris. 1995. Mutations in the p161NK4/ MTS1/CDKN2, p151NK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 55:1448-1451.
20. Wang, X. W., M. S. Greenblatt, and C. C. Harris. 1948. Molecular genetics of lung cancer. In Clinical and Biological Basis of Lung Cancer Prevention. Y. Martinet, F. R. Hirsch, N. Martinet, J.-M. Vignaud, and J. I., Mulshine, editors. Birkhauser-Verlag. Basel. Chap. 10. 117-127.